Sort by
Refine Your Search
-
Start date: 1st July 2024 Fixed-term: The funds for this time-limited post are available until 31st January 2025. Applications are invited for a postdoctoral research position in the Materials Theory Group led by Professor Pickard at the Department of Materials Science and Metallurgy, University...
-
these challenges by developing, testing, and validating a systematic methodology to understand and quantify energy performance of battery electric HGVs, with a focus on the performance of vehicle traction battery
-
The High Energy Physics group at the University of Cambridge seeks to appoint an outstanding researcher to join its effort on the LHCb experiment. One full-time-equivalent position is envisaged
-
Decarbonizing the global economy can only be achieved by reducing the carbon intensity of energy sources. A key to achieving this is reducing the techno-economic barriers to replacing fossil fuel
-
The Role: The University of Cambridge is seeking a knowledgeable and committed individual to join the University's Estates Operation Team as its Building Energy Manager.¿ This is a key role for
-
THE GROUP We are seeking a highly motivated cell biologist to join Dr. Naomi McGovern's laboratory. The lab works on human mononuclear phagocytes and how their properties are regulated by the local
-
. The project will use state-of-the-art genomic technologies to identify epigenetic determinants that lead to protein misfolding in neurons. Using single-cell technologies for in vivo mouse models as
-
in either microfluidic methods, hydrogels for 2D/3D cell culture, or micromechanics of biological tissues. Excellent organizational skills and the desire to work as part of an inter-disciplinary team
-
of healthy volunteers and patients with a variety of neurological and neurosurgical conditions. ICARUS provides bespoke tissue, cell lines, liquid biopsies and associated data for multiple fundamental
-
collaborative Wellcome Discovery Award, to characterise novel cellular models of mitochondrial disease, and use single-cell forward genetic screening approaches to characterise novel nuclear modifiers of disease